Abstract:Individuals with spinal cord injuries (SCI) have a greater incidence of cardiovascular disease (CVD) than the non‐injured. Contributing to the increased CVD is decreased cardiometabolic health including increased insulin resistance, central adiposity, and dyslipidemia. In fact, cross‐sectional analyses of individuals with chronic SCI (up to 50 years post injury) indicates that up to 70% are classified as overweight/obese and 25‐60% have either insulin resistance or dyslipidemia. However, current understanding of cardiometabolic health in SCI derives from those with chronic injury, hence it is unknown if biomarkers are adversely affected in those with more acute injuries. Therefore, we assessed cardiometabolic health in individuals with SCI <3 yrs. Cardiometabolic health was assessed through fasting blood glucose, insulin, triglycerides, low density lipoprotein (LDL), high density lipoprotein (HDL), total cholesterol, C‐reactive protein (CRP), and hemoglobin A1C (HbA1C). In addition, oral glucose tolerance testing (OGTT) was performed, and body composition was estimated via dual energy x‐ray absorptiometry (DXA). Five individuals (1F, 4M) aged 20 to 34 yo with SCI at neurologic level of injury ranging from spinal cord segments C6 to T4 (ASIA A and B) at 9 to 27 months post‐injury participated. All subjects displayed at ≥1 marker of impaired cardiometabolic health, while one displayed five markers. Body fat ranged from 27 to 42%, and one subject was classified as obese, two as overweight, and two as normal weigh based on BMI. Dyslipidemia was prominent in four of five subjects: one had elevated total cholesterol (>200 mg/dL), one had elevated triglycerides (>150 mg/dL), three had low HDL (<40 mg/dL), and two had elevated LDL (>100 mg/dL). Glucose tolerance test data and fasting insulin measurements showed normal fasting glucose (<100 mg/dl), HOMA‐IR (<2.0), and HbA1C (<5.7%) in all individuals, but one subject displayed impaired glucose tolerance during the OGTT (1 hr post >200 mg/dL, 2hr post >180 mg/dL). Three of five subjects had CRP levels >3.0, suggesting an increased inflammatory state. These preliminary results strongly suggest that cardiometabolic health may be impaired within 3 years after SCI. These biomarkers of altered cardiometabolic health, specifically related to lipid dysregulation, may reflect adipose tissue dysfunction, possibly in response to the accumulation of adipose tissue and/or the decreased physical activity, increased sedentary activity, and skeletal muscle atrophy that typically occurs following a spinal injury. More research is needed to determine the mediators of impaired cardiometabolic health in subjects with SCI and determine effective strategies to mitigate the detrimental effects of SCI on cardiometabolic health.

A retrospective study on bone metabolism biochemical markers change in patients with spinal cord injury

Long-term changes in bone mineral density and associated risk factors in individuals with spinal cord injury: A retrospective study

A comprehensive study of long-term skeletal changes after spinal cord injury in adult rats

Bone microarchitectural alterations associated with spinal cord injury: Relation to sex hormones, metabolic factors, and loading

Exploring changes in bone mass in individuals with a chronic spinal cord injury

Diagnosis value of bone metabolic markers in primary osteoporosis

Relationship among bone metabolic markers, bone mineral density and calcium, phosphorus, metal elements contents in bone tissue

Correlation analysis of serum 25-hydroxyvitamin D and bone turnover markers in senile patients with hip fractures

Age-related Changes of Serum Bone Alkaline Phosphatase and Cross-Linked C-telopeptides of Type I Collagen and the Relationship with Bone Mineral Density in Chinese Women

Individuals with Acute Spinal Cord Injury Display Impaired Biomarkers of Cardiometabolic Health

Value of Biochemical Indexes of Bone Metabolism in Predicting Osteoporotic Lumbar Fractures

The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study

Basal Metabolic Rate Versus Dietary Vitamin D and Calcium Intakes and the Association With Body Composition and Bone Health After Chronic Spinal Cord Injury

Changes of bone mineral density in association with serum interleukin-6 in adolescent idiopathic scoliosis

Association of Higher Bone Turnover with Risk of Curve Progression in Adolescent Idiopathic Scoliosis

Relationship between serum vitamin D level and bone metabolism with 1389 cases analysis

Relationship between spinal bone mineral density measured by quantitative CT and bone metabolism related index in the patients with chronic kidney disease

The vitamin D status in a Chinese osteogenesis imperfecta population and its correlation with bone metabolic markers and bone density

Interrelations among Vascular Calcification, Bone Density, Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kb Ligand in Hemodialysis Patients

Measurement of Bone: Diagnosis of SCI-Induced Osteoporosis and Fracture Risk Prediction.

The Effects of Vitamin D Deficiency on Bone Turnover and Bone Mineral Density in Patients with Different PTH Responses in Postmenopausal Women